Literature DB >> 22682293

A review of influenza haemagglutinin receptor binding as it relates to pandemic properties.

Sam Wilks1, Miranda de Graaf, Derek J Smith, David F Burke.   

Abstract

Haemagglutinin is a determinant of many viral properties, and successful adaptation to a human-like form is thought to be an important step toward pandemic influenza emergence. The availability of structurally distinct sialic acid linked receptors in the sites of human and avian influenza infection are generally held to account for the differences observed, but the relevance of other selection pressures has not been elucidated. There is evidence for genetic and structural constraints of haemagglutinin playing a role in restricting haemagglutinin adaptation, and also for differences in the selection pressure to alter binding, specifically when considering virus replication within host compared to transmission between hosts. Understanding which characteristics underlie such adaptations in humans is now possible in greater detail by using glycan arrays. However, results from these assays must also interpreted in context of an as yet still to be determined detailed knowledge of the structural diversity of sialic acids in the human respiratory tract. A clearer understanding of the evolutionary benefits conveyed by different haemagglutinin properties would have substantial impact and would affect the risk we allocate to viral propagation in different species, such as swine and poultry. Relevant to the H5N1 threat, current evidence also suggests that mortality associated with any emergent pandemic from current strains may be reduced if haemagglutinin specificity changes, further emphasising the importance of understanding how and if selection pressures in the human will cause such an alteration.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682293      PMCID: PMC3372863          DOI: 10.1016/j.vaccine.2012.02.076

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  49 in total

1.  A history of influenza.

Authors:  C W Potter
Journal:  J Appl Microbiol       Date:  2001-10       Impact factor: 3.772

Review 2.  Avian influenza A (H5N1) infection in humans.

Authors:  John H Beigel; Jeremy Farrar; Aye Maung Han; Frederick G Hayden; Randy Hyer; Menno D de Jong; Sorasak Lochindarat; Thi Kim Tien Nguyen; Tran Hien Nguyen; Tinh Hien Tran; Angus Nicoll; Sok Touch; Kwok-Yung Yuen
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

3.  Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium.

Authors:  Mikhail Matrosovich; Tatyana Matrosovich; Jennifer Uhlendorff; Wolfgang Garten; Hans-Dieter Klenk
Journal:  Virology       Date:  2007-01-17       Impact factor: 3.616

Review 4.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

5.  Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation.

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Geert van Amerongen; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan; Thijs Kuiken
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

6.  Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses.

Authors:  Taronna R Maines; Li-Mei Chen; Neal Van Hoeven; Terrence M Tumpey; Ola Blixt; Jessica A Belser; Kortney M Gustin; Melissa B Pearce; Claudia Pappas; James Stevens; Nancy J Cox; James C Paulson; Rahul Raman; Ram Sasisekharan; Jacqueline M Katz; Ruben O Donis
Journal:  Virology       Date:  2011-03-23       Impact factor: 3.616

7.  Different cell-surface receptor determinants of antigenically similar influenza virus hemagglutinins.

Authors:  S M Carroll; H H Higa; J C Paulson
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

8.  Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China.

Authors:  Hua Wang; Zijian Feng; Yuelong Shu; Hongjie Yu; Lei Zhou; Rongqiang Zu; Yang Huai; Jie Dong; Changjun Bao; Leying Wen; Hong Wang; Peng Yang; Wei Zhao; Libo Dong; Minghao Zhou; Qiaohong Liao; Haitao Yang; Min Wang; Xiaojun Lu; Zhiyang Shi; Wei Wang; Ling Gu; Fengcai Zhu; Qun Li; Weidong Yin; Weizhong Yang; Dexin Li; Timothy M Uyeki; Yu Wang
Journal:  Lancet       Date:  2008-04-08       Impact factor: 79.321

Review 9.  Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues.

Authors:  Timothy M Uyeki
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

10.  Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.

Authors:  Guadalupe Ayora-Talavera; Holly Shelton; Margaret A Scull; Junyuan Ren; Ian M Jones; Raymond J Pickles; Wendy S Barclay
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

View more
  28 in total

1.  Full sequence analysis of hemagglutinin and neuraminidase genes and proteins of highly pathogenic avian influenza H5N1 virus detected in Iran, 2015.

Authors:  Sima Yegani; Abdel-Hamid Shoushtari; Fatemeh Eshratabadi; Aidin Molouki
Journal:  Trop Anim Health Prod       Date:  2018-10-27       Impact factor: 1.559

2.  A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor.

Authors:  Brook E Heaton; Edward M Kennedy; Rebekah E Dumm; Alfred T Harding; Matthew T Sacco; David Sachs; Nicholas S Heaton
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

Review 3.  Connecting the study of wild influenza with the potential for pandemic disease.

Authors:  Jonathan Runstadler; Nichola Hill; Islam T M Hussein; Wendy Puryear; Mandy Keogh
Journal:  Infect Genet Evol       Date:  2013-03-26       Impact factor: 3.342

Review 4.  The weight of obesity on the human immune response to vaccination.

Authors:  Scott D Painter; Inna G Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2015-07-08       Impact factor: 3.641

5.  Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes.

Authors:  Lauren Byrd-Leotis; Summer E Galloway; Evangeline Agbogu; David A Steinhauer
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

6.  The arrival of highly pathogenic avian influenza viruses H5N8 in Iran through two windows, 2016.

Authors:  Minoo Motahhar; Hadi Keyvanfar; Abdolhamid Shoushtari; Mohammad Hossein Fallah Mehrabadi; Gholamreza Nikbakht Brujeni
Journal:  Virus Genes       Date:  2022-09-13       Impact factor: 2.198

7.  Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

Authors:  Emma R Job; Barbara Bottazzi; Brad Gilbertson; Kathryn M Edenborough; Lorena E Brown; Alberto Mantovani; Andrew G Brooks; Patrick C Reading
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

8.  The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation.

Authors:  Antonio Inforzato; Patrick C Reading; Elisa Barbati; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Front Immunol       Date:  2013-01-07       Impact factor: 7.561

9.  The exploitation of human glycans by Group A Streptococcus.

Authors:  Anuk D Indraratna; Arun Everest-Dass; Danielle Skropeta; Martina Sanderson-Smith
Journal:  FEMS Microbiol Rev       Date:  2022-05-06       Impact factor: 15.177

10.  Model-based simulation and prediction of an antiviral strategy against influenza A infection.

Authors:  Kye-Yeon Hur; Joon-Young Moon; Seung-Hwan Kim; Joo-Yeon Yoo
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.